Clinical Trial Update: A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study of HG146 Capsule in Chinese subjects with relapsed and refractory multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And Refractory Multiple Myeloma
• Multiple Myeloma

Drugs mentioned

• HG146 Capsule

Snippet

Sponsor: HitGen Inc. | Conditions: Multiple Myeloma, Relapsed and Refractory Multiple Myeloma | Phase 1 | Status: TERMINATED